Trimethoprim-induced aseptic meningism.

Ni Lochlainn, Mary; Gooi, Hock C; Ogese, Monday O; Naisbitt, Dean J; Jafar-Mohammadi, Bahram

Ni Lochlainn, Mary; Gooi, Hock C; Ogese, Monday O; Naisbitt, Dean J; Jafar-Mohammadi, Bahram.

Afiliação

Ni Lochlainn M; Foundation Doctor, Department of Geriatric Medicine, King's College Hospital, London SE5 9RS.
Gooi HC; Consultant, Department of Immunology, King's College Hospital, London.
Ogese MO; Post-doctoral Research Associate, Pathology Sciences, Drug Safety and Metabolism, AstraZeneca R&D, Cambridge Science Park, Cambridge.
Naisbitt DJ; Reader, Department of Pharmacology, University of Liverpool, Liverpool.
Jafar-Mohammadi B; Consultant, Department of Endocrinology, King's College Hospital, London.

Br J Hosp Med (Lond) ; 78(2): 108-109, 2017 02 02.

Article em En | MEDLINE | ID: mdl-28165786

Assuntos

Antibacterianos/efeitos adversos; Meningismo/induzido quimicamente; Combinação Trimetoprima e Sulfametoxazol/efeitos adversos; Adulto; Feminino; Humanos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Combinação Trimetoprima e Sulfametoxazol / Meningismo / Antibacterianos Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google